Insulin

At the recent 44th annual meeting of the European Association for the Study of Diabetes (EASD), sanofi-aventis announced a study demonstrating that a basal-bolus insulin regimen with Lantus® once daily (basal insulin) and rapid-acting Apidra® (insulin glulisine [rDNA origin] injection) at mealtime (bolus insulin) resulted in significant A1c reductions from baseline as compared to pre-mixed insulin in people with type 2 diabetes.

2 comments - Sep 29, 2008 -

By "reprogramming" adult exocrine cells in mice pancreases to function as beta-like insulin producers, Harvard biologists have taken a giant step toward the use of cell regeneration therapy in the treatment of type 1 diabetes.

0 comments - Sep 4, 2008 -

Results from a Harris survey commissioned by the American Association of Diabetes Educators (AADE) show that people with diabetes who must take insulin often struggle with dread and negative impacts on their lives because of it. But more than half of them—52 percent—are reluctant to share their concerns with their healthcare providers.

10 comments - Aug 14, 2008 -

A study of beta cells at McGill University Health Centre in Montreal could hold significant promise for people with type 1 diabetes.

0 comments - Aug 5, 2008 -

When the National Federation of the Blind (NFB) hosted its convention June 30 through July 5 in Dallas, Texas, it awarded the Access Plus (A+) Award to Diagnostic Devices, Inc., makers of Prodigy® blood glucose monitoring systems. “The A+ Award program was designed to reward companies that make consumer products that are truly accessible for blind people,” said Eileen Rivera Ley, Director of Diabetes Initiatives for the NFB. The A+ Award is for products that afford the blind the same convenience and features available to everyone else and is awarded only to products and services that meet the highest standards of accessibility.

0 comments - Aug 5, 2008 -

In a report published in the December 23, 2000, issue of the British Medical Journal (BMJ), researchers at the University of Liverpool in the United Kingdom write that hypoglycemia is one of the complications of diabetes most feared by patients. They point out, "Intensive research has been devoted to the development of hypoglycemia alarms."

8 comments - Jul 31, 2008 -

July 27, 2008 marked the eighth full month that my son has not used insulin. His last A1c was 5.9%, on July 9, 2008. On August 14th of this year, it will be one year since he was originally diagnosed with type 1. As you know, he was taken off insulin on November 27, 2007, about a month after getting the experimental drug teplizumab. I don't know if it is the drug or not, but others have taken it with good results. It will be interesting to see if they ever get the drug approved and can use it quickly on newly diagnosed type 1s.

13 comments - Jul 31, 2008 -

If you are a New Yorker and have been denied CGMS coverage by insurance or would like coverage for a continuous glucose monitoring system, Gina Capone, founder of Diabetes TalkFest, wants you to Raise your Voice.

3 comments - Jul 24, 2008 -

The provincial government of Ontario has announced it will spend $741 million over the next four years to combat diabetes, including paying the costs of insulin pumps for adults with type 1 diabetes.

4 comments - Jul 24, 2008 -

Before diabetes, I was a normal teenager whose greatest worry was whether I’d get an A or a B on a test. I was strong and healthy. Somehow, I took for granted all the freedoms that diabetes took away from me. Last year, at the age of fifteen, I learned that every day, even every breath, that we are given is a true gift.

2 comments - Jul 24, 2008 -